Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Best Agro-Chemical Stocks To Buy Now: Microsec Report



Ajoy Mukherjee of Microsec has issued a comprehensive report in which he has conducted a thorough review of the best agro-chemical companies and given clear-cut recommendations of stocks to buy




NAMO has made it clear that his focus area is agriculture and that he wants to usher in the next “Green Revolution”.

EXCLUSIVE LAUNCH OF SAMSUNG GALAXY K ZOOM (Available for Pre-order with free gifts worth Rs 6000!)

Ajoy Mukherjee has issued a report in which he has discussed the merits and drawbacks of top agro-chemical stocks like Bayer Cropscience Ltd, BASF Ltd, Atul Ltd, UPL Ltd, PI Industries, Monsanto India Ltd, Rallis India Ltd etc. A clear recommendation of “strong buy” on a few chosen stocks has been given together with a detailed rationale.

Click here to download Microsec’s research report on Agro-Chemical stocks to buy now
investments, Portfolio    ,

1 Comment
  1. zarahnitsa's Gravatar zarahnitsa
    October 10, 2014 at 11:00 am | Permalink

    You have shared good tips for chemical stocks.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 494 other subscribers

RSS Stocks Talk Forum

  • Shalby is a multi-specialty hospital chain with expertise in joint replacement
    Shalby is a multi-specialty hospital chain with expertise in joint replacement. It is making right strides with calibrated growth based on big ticket expansion in metros & tier I cities & asset-light franchisee expansion in tier II-VI towns. TP ₹310 (35%) Download... Shalby is a multi-specialty hospital chain with expertise in joint replacement
  • DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
    DLF has strong growth prospects due to strong sectoral tailwinds, record low inventory, greater preference for branded luxury, extensive launch pipeline & expansion in its annuity portfolio. Strong Balance Sheet with consistent cash flow. TP ₹1081 (+30%) Research Report... DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
  • Aditya Birla Capital has demonstrated solid performance. Buy for target price of ₹280 (37% upside)
    Aditya Birla Capital has demonstrated solid performance, achieving strong growth in the loan book while maintaining asset quality. Management has reiterated guidance on both growth & credit cost fronts. Lending business expected to grow at 30%. TP (+37%)... Aditya Birla Capital has demonstrated solid performance. Buy for target price of ₹280 (37% upside)
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!